Scharrer

401 total citations
3 papers, 306 citations indexed

About

Scharrer is a scholar working on Hematology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Scharrer has authored 3 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hematology, 1 paper in Molecular Biology and 0 papers in Infectious Diseases. Recurrent topics in Scharrer's work include Hemophilia Treatment and Research (3 papers), Hemostasis and retained surgical items (2 papers) and Platelet Disorders and Treatments (1 paper). Scharrer is often cited by papers focused on Hemophilia Treatment and Research (3 papers), Hemostasis and retained surgical items (2 papers) and Platelet Disorders and Treatments (1 paper). Scharrer collaborates with scholars based in Germany and United States. Scharrer's co-authors include Bray and has published in prestigious journals such as Haemophilia.

In The Last Decade

Scharrer

3 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scharrer Germany 3 288 64 47 16 9 3 306
G. Auerswald Germany 10 376 1.3× 121 1.9× 35 0.7× 11 0.7× 7 0.8× 14 397
Amy Shapiro United States 5 483 1.7× 122 1.9× 65 1.4× 6 0.4× 14 1.6× 5 517
F. Abdul Karim Denmark 6 350 1.2× 93 1.5× 53 1.1× 16 1.0× 8 0.9× 10 369
Glaivy Batsuli United States 8 235 0.8× 72 1.1× 36 0.8× 20 1.3× 9 1.0× 23 260
Alice S. van Velzen Netherlands 10 219 0.8× 62 1.0× 49 1.0× 13 0.8× 3 0.3× 17 232
M. Oh United States 6 592 2.1× 174 2.7× 60 1.3× 9 0.6× 8 0.9× 8 615
Susan Pemberton United Kingdom 9 412 1.4× 116 1.8× 102 2.2× 15 0.9× 7 0.8× 11 442
Carme Altisent Spain 9 181 0.6× 27 0.4× 71 1.5× 2 0.1× 13 1.4× 15 197
Avrita Campinha‐Bacote United States 5 319 1.1× 101 1.6× 17 0.4× 8 0.5× 15 1.7× 8 344
Valentín Cabañas Spain 6 66 0.2× 20 0.3× 51 1.1× 7 0.4× 18 2.0× 11 106

Countries citing papers authored by Scharrer

Since Specialization
Citations

This map shows the geographic impact of Scharrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scharrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scharrer more than expected).

Fields of papers citing papers by Scharrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scharrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scharrer. The network helps show where Scharrer may publish in the future.

Co-authorship network of co-authors of Scharrer

This figure shows the co-authorship network connecting the top 25 collaborators of Scharrer. A scholar is included among the top collaborators of Scharrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scharrer. Scharrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
2.
Scharrer. (1999). Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency. Haemophilia. 5(4). 253–259. 106 indexed citations
3.
Scharrer, et al.. (1999). German recommendations for immune tolerance therapy in type A haemophiliacs with antibodies. Haemophilia. 5(3). 203–206. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026